Serina Therapeutics Inc. (SER) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Serina Therapeutics Inc.

NYSE: SER · Real-Time Price · USD
4.97
-0.01 (-0.20%)
At close: Sep 26, 2025, 3:54 PM
4.93
-0.80%
After-hours: Sep 26, 2025, 06:22 PM EDT

Serina Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-11.21M 5.27M -2.68M -1.26M
Depreciation & Amortization
194K 90K 61.27K 33.37K
Stock-Based Compensation
2.6M 25K 7.11K 82.94K
Other Working Capital
-1.72M -312K 153.5K -1.61M
Other Non-Cash Items
-5.4M -7.94M 148.25K -122.21K
Deferred Income Tax
n/a n/a 401.79K -225.38K
Change in Working Capital
-3.32M 81K -11.94K -754.79K
Operating Cash Flow
-17.14M -2.48M -2.08M -2.25M
Capital Expenditures
-22K -504K -9.68K -108.43K
Cash Acquisitions
n/a n/a n/a 466K
Purchase of Investments
n/a n/a n/a -666K
Sales Maturities Of Investments
n/a n/a 990.62K 931.75K
Other Investing Acitivies
n/a n/a n/a 200K
Investing Cash Flow
-22K -504K 980.94K 823.32K
Debt Repayment
2.88M 10.05M 1.31M -12.91K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
5.34M n/a n/a 1M
Financial Cash Flow
13.21M 10.07M 1.31M 1.08M
Net Cash Flow
-3.95M 7.09M 217.38K -350.21K
Free Cash Flow
-17.16M -2.98M -2.09M -2.36M